Merck earnings miss, Revenue beats in Q2

  • Investing.com
Merck earnings miss, Revenue beats in Q2

Investing.com - Merck (NS: PROR ) reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations.

Merck announced earnings per share of €1.99 on revenue of €5.57B. Analysts polled by Investing.com anticipated EPS of €2.49 on revenue of €5.42B.

Merck shares are down 18% from the beginning of the year and are trading at €185.75 , down-from-52-week-high.They are under-performing the DAX which is down 13.99% year to date.

Merck follows other major Healthcare sector earnings this month

Merck's report follows an earnings missed by Siemens Healthineers on Wednesday, who reported EPS of €0.43 on revenue of €5.19B, compared to forecasts EPS of €0.4789 on revenue of €5.05B.

Bayer had beat expectations on Thursday with second quarter EPS of €1.93 on revenue of €12.82B, compared to forecast for EPS of €1.9 on revenue of €12.33B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles